DRI Healthcare Trust
TSX:DHT-U.TO · Toronto Stock Exchange
-$0.23 today
Vol 0.00M · Avg 0.00M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
TSX:DHT-U.TO · Revenue to Net Income
Key Ratios
Analysis
$198.6M of revenue converted into -$49.6M of net income for the selected period. Gross margin is 22.8% and net margin is -27.7%, showing how much revenue survives after costs and taxes. EPS is $-0.88, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $195.2M +40.9% | $138.5M +18.0% | $117.4M +47.0% | $79.9M +8.9% | $73.3M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $216.7M +201.2% | $71.9M -47.8% | $137.8M | $0 | $0 | $725.6M | $804.0M | $882.4M |
| Gross Profit | -$21.5M -132.3% | $66.6M +427.2% | -$20.4M -125.5% | $79.9M +8.9% | $73.3M | $8.9B | $7.6B | $6.2B |
| Gross Margin | -11.0% -59.1pp | 48.1% +65.4pp | -17.3% -117.3pp | 100.0% +0.0pp | 100.0% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $66.9M +327.3% | $15.7M +110.3% | $7.4M -1.5% | $7.6M -20.1% | $9.5M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | -$82.8M -395.5% | $28.0M -69.8% | $92.9M +36.1% | $68.3M +31.9% | $51.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $103.8M +5.9% | $97.9M +10.1% | $88.9M +50.0% | $59.3M +41.7% | $41.8M | $374.2M | $1.2B | $631.8M |
| EBITDA | $92.3M +1967.8% | -$4.9M -104.6% | $107.5M +40.1% | $76.8M +16.2% | $66.1M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 47.3% +50.8pp | -3.6% -95.1pp | 91.6% -4.6pp | 96.1% +6.0pp | 90.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $61.3M -61.4% | $159.0M +754.6% | $18.6M +60.4% | $11.6M -46.2% | $21.6M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 31.4% -83.3pp | 114.7% +98.9pp | 15.8% +1.3pp | 14.5% -14.9pp | 29.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $1.1M -60.3% | $2.8M -35.0% | $4.3M -25.1% | $5.8M +202.4% | $1.9M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $40.4M +14.0% | $35.4M +33.7% | $26.5M +299.7% | $6.6M +196.5% | $2.2M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$113.2M +30.3% | -$162.3M -320.2% | $73.7M +213.1% | -$65.2M -30.0% | -$50.1M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$51.9M -1442.5% | -$3.4M -103.6% | $92.3M +695.9% | $11.6M -46.2% | $21.6M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -26.6% -24.2pp | -2.4% -81.0pp | 78.6% +64.1pp | 14.5% -14.9pp | 29.4% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$534.2K | $0 -100.0% | $808.0K +112.2% | -$6.6M -130.6% | -$2.9M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$51.4M -1426.6% | -$3.4M -103.7% | $91.5M +688.9% | $11.6M -46.2% | $21.6M | $4.9B | $4.8B | $4.7B |
| Net Margin | -26.3% -23.9pp | -2.4% -80.3pp | 77.9% +63.4pp | 14.5% -14.9pp | 29.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 -1441.0% | -$0 -102.9% | $2 +593.3% | $0 -51.6% | $1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 -1433.3% | -$0 -102.9% | $2 +590.0% | $0 -51.6% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $40.6M -28.0% | $56.3M +26.7% | $44.5M +15.3% | $38.6M +11.3% | $34.6M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $40.6M -28.0% | $56.3M +26.3% | $44.6M +15.6% | $38.6M +11.4% | $34.7M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Dexterra Group Inc.
TSX:DXT.TO
$809.53M
DRI Healthcare Trust
DHT-UN.TO
$672.75M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$462.27M
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
$408.04M
Dream Residential Real Estate Investment Trust
DRR-U.TO
$211.15M
OrganiGram Holdings Inc.
TSX:OGI.TO
$189.69M
HLS Therapeutics Inc.
TSX:HLS.TO
$131.35M
European Residential Real Estate Investment Trust
ERE-UN.TO
$110.80M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does DHT-U.TO generate?
DRI Healthcare Trust (DHT-U.TO) reported $195.17M of revenue in fiscal 2025.
Is DHT-U.TO profitable?
DRI Healthcare Trust (DHT-U.TO) reported -$51,354,521.00 of net income, with a net margin of -26.3%.
Explore More
Continue the stock analysis
Jump to another research area for this company.